Clinical Trial Update: Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and feasibility of combining oxaliplatin, gemcitabine, erlotinib, and radiation therapy in patients with unresectable or m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extrahepatic Cholangiocarcinoma
• Gallbladder Cancer
• Pancreatic Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Gemzar (gemcitabine)
• Tarceva (erlotinib)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Extrahepatic Bile Duct Cancer, Gallbladder Cancer | Phase 1 | Status: COMPLETED